Thrombospondin-1 prevents excessive ossification in cartilage repair tissue induced by osteogenic protein-1

Tissue Engineering - Part A

Volumn 17, Issue 15-16, 2011, Pages 2101-2112

  Gelse, Kolja ^a   Klinger, Patricia ^b   Koch, Matthias ^a   Surmann Schmitt, Cordula ^c   Von Der Mark, Klaus ^c   Swoboda, Bernd ^b   Hennig, Friedrich F ^a   Gusinde, Johannes ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b Department of Orthopaedic Rheumatology ^*  (Germany)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BODY FLUIDS; BONE; COLLAGEN; REPAIR; TISSUE;

ARTICULAR CARTILAGES; BONE FORMATION; CARTILAGE REPAIR; CHONDROCYTES; CHONDROGENESIS; ENDOCHONDRAL OSSIFICATION; IMMUNOHISTOCHEMICAL METHODS; MICRO-FRACTURE; OSTEOGENIC; REPAIR TISSUES;

CARTILAGE;

SUIDAE;

OSTEOGENIC PROTEIN 1; THROMBOSPONDIN 1;

ANGIOGENESIS; ANIMAL; ARTICLE; ARTICULAR CARTILAGE; BLOOD VESSEL; BONE DEVELOPMENT; CARTILAGE CELL; CELL DIFFERENTIATION; CHONDROGENESIS; DRUG EFFECT; ENDOTHELIUM CELL; FEMALE; HUMAN; HYPERTROPHY; MECHANICAL STRESS; MINIPIG; PATHOLOGY; SWINE; WOUND HEALING;

ANIMALS; BLOOD VESSELS; BONE MORPHOGENETIC PROTEIN 7; CARTILAGE, ARTICULAR; CELL DIFFERENTIATION; CHONDROCYTES; CHONDROGENESIS; ENDOTHELIAL CELLS; FEMALE; HUMANS; HYPERTROPHY; NEOVASCULARIZATION, PHYSIOLOGIC; OSTEOGENESIS; STRESS, MECHANICAL; SWINE; SWINE, MINIATURE; THROMBOSPONDIN 1; WOUND HEALING;

EID: 79960755037     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2010.0691     Document Type: Article

References (53)

1. Park, J., Gelse, K., Frank, S., von der Mark, K., Aigner, T., and Schneider, H. Transgene-activated mesenchymal cells for articular cartilage repair: a comparison of primary bone marrow-, perichondrium/periosteum-and fat-derived cells. J Gene Med 8, 112, 2006.
2. Pittenger, M.F., Mackay, A.M., Beck, S.C., Jaiswal, R.K., Douglas, R., Mosca, J.D., Moorman, M.A., Simonetti, D.W., Craig, S., and Marshak, D.R. Multilineage potential of adult human mesenchymal stem cells. Science 284, 143, 1999.
3. Gelse, K., Olk, A., Eichhorn, S., Swoboda, B., Schoene, M., and Raum, K. Quantitative ultrasound biomicroscopy for the analysis of healthy and repair cartilage tissue. Eur Cell Mater 19, 58, 2010.
4. Shapiro, F., Koide, S., and Glimcher, M.J. Cell origin and differentiation in the repair of full-thickness defects of articular cartilage. J Bone Joint Surg Am 75, 532, 1993.
5. Saris, D.B., Vanlauwe, J., Victor, J., Haspl, M., Bohnsack, M., Fortems, Y., Vandekerckhove, B., Almqvist, K.F., Claes, T., Handelberg, F., Lagae, K., van der Bauwhede, J., Vandenneucker, H., Yang, K.G., Jelic, M., Verdonk, R., Veulemans, N., Bellemans, J., and Luyten, F.P. Characterized chondrocyte implantation results in better structural repair when treating symptomatic cartilage defects of the knee in a randomized controlled trial versus microfracture. Am J Sports Med 36, 235, 2008.
6. Louwerse, R.T., Heyligers, I.C., Klein-Nulend, J., Sugihara, S., van Kampen, G.P., Semeins, C.M., Goei, S.W., de Koning, M.H., Wuisman, P.I., and Burger, E.H. Use of recombinant human osteogenic protein-1 for the repair of subchondral defects in articular cartilage in goats. J Biomed Mater Res 49, 506, 2000.
7. Cook, S.D., Patron, L.P., Salkeld, S.L., and Rueger, D.C. Repair of articular cartilage defects with osteogenic protein-1 (BMP-7) in dogs. J Bone Joint Surg Am 85-A Suppl 3, 116, 2003.
8. Mason, J.M., Breitbart, A.S., Barcia, M., Porti, D., Pergolizzi, R.G., and Grande, D.A. Cartilage and bone regeneration using gene-enhanced tissue engineering. Clin Orthop 379 Suppl, S171, 2000.
9. Kuo, A.C., Rodrigo, J.J., Reddi, A.H., Curtiss, S., Grotkopp, E., and Chiu, M. Microfracture and bone morphogenetic protein 7 (BMP-7) synergistically stimulate articular cartilage repair. Osteoarthritis Cartilage 14, 1126, 2006.
10. Fischer, J., Dickhut, A., Rickert, M., and Richter, W. Human articular chondrocytes secrete parathyroid hormone-related protein and inhibit hypertrophy of mesenchymal stem cells in coculture during chondrogenesis. Arthritis Rheum 62, 2696, 2010.
11. Mehlhorn, A.T., Niemeyer, P., Kaiser, S., Finkenzeller, G., Stark, G.B., Sudkamp, N.P., and Schmal, H. Differential expression pattern of extracellular matrix molecules during chondrogenesis of mesenchymal stem cells from bone marrow and adipose tissue. Tissue Eng 12, 2853, 2006.
12. Varkey, M., Kucharski, C., Doschak, M.R., Winn, S.R., Brochmann, E.J., Murray, S., Matyas, J.R., Zernicke, R.F., and Uludag, H. Osteogenic response of bone marrow stromal cells from normal and ovariectomized rats treated with a low dose of basic fibroblast growth factor. Tissue Eng 13, 809, 2007.
13. Mithoefer, K., Williams, R.J., 3rd, Warren, R.F., Potter, H.G., Spock, C.R., Jones, E.C., Wickiewicz, T.L., and Marx, R.G. The microfracture technique for the treatment of articular cartilage lesions in the knee. A prospective cohort study. J Bone Joint Surg Am 87, 1911, 2005.
14. Henderson, I.J., and La Valette, D.P. Subchondral bone overgrowth in the presence of full-thickness cartilage defects in the knee. Knee 12, 435, 2005.
15. Kreuz, P.C., Steinwachs, M.R., Erggelet, C., Krause, S.J., Konrad, G., Uhl, M., and Sudkamp, N. Results after microfracture of full-thickness chondral defects in different compartments in the knee. Osteoarthritis Cartilage 14, 1119, 2006.
16. Volk, S.W., Luvalle, P., Leask, T., and Leboy, P.S. A BMP responsive transcriptional region in the chicken type X collagen gene. J Bone Miner Res 13, 1521, 1998.
17. Rutherford, R.B., Moalli, M., Franceschi, R.T., Wang, D., Gu, K., and Krebsbach, P.H. Bone morphogenetic proteintransduced human fibroblasts convert to osteoblasts and form bone in vivo. Tissue Eng 8, 441, 2002.
18. Harada, S., Sampath, T.K., Aubin, J.E., and Rodan, G.A. Osteogenic protein-1 up-regulation of the collagen X promoter activity is mediated by aMEF-2-like sequence and requires an adjacent AP-1 sequence. Mol Endocrinol 11, 1832, 1997.
19. Schipani, E., Ryan, H.E., Didrickson, S., Kobayashi, T., Knight, M., and Johnson, R.S. Hypoxia in cartilage: HIF-1alpha is essential for chondrocyte growth arrest and survival. Genes Dev 15, 2865, 2001.
20. Lafont, J.E., Talma, S., Hopfgarten, C., and Murphy, C.L. Hypoxia promotes the differentiated human articular chondrocyte phenotype through SOX9-dependent and-independent pathways. J Biol Chem 283, 4778, 2008.
21. Blanke, M., Carl, H.D., Klinger, P., Swoboda, B., Hennig, F., and Gelse, K. Transplanted chondrocytes inhibit endochondral ossification within cartilage repair tissue. Calcif Tissue Int 85, 421, 2009.
22. Iruela-Arispe, M.L., Liska, D.J., Sage, E.H., and Bornstein, P. Differential expression of thrombospondin 1, 2, and 3 during murine development. Dev Dyn 197, 40, 1993.
23. Hsieh, J.L., Shen, P.C., Shiau, A.L., Jou, I.M., Lee, C.H., Wang, C.R., Teo, M.L., and Wu, C.L. Intraarticular gene transfer of thrombospondin-1 suppresses the disease progression of experimental osteoarthritis. J Orthop Res 28, 1300, 2010.
24. Gelse, K., Muhle, C., Franke, O., Park, J., Jehle, M., Durst, K., Goken, M., Hennig, F., Mark, K.V., and Schneider, H. Cellbased resurfacing of large cartilage defects: Long-term evaluation of grafts from autologous transgene-activated periosteal cells in a porcine model of osteoarthritis. Arthritis Rheum 58, 475, 2008.
25. Girkontaite, I., Frischholz, S., Lammi, P., Wagner, K., Swoboda, B., Aigner, T., and Von der Mark, K. Immunolocalization of type X collagen in normal fetal and adult osteoarthritic cartilage with monoclonal antibodies. Matrix Biol 15, 231, 1996.
26. Mainil-Varlet, P., Aigner, T., Brittberg, M., Bullough, P., Hollander, A., Hunziker, E., Kandel, R., Nehrer, S., Pritzker, K., Roberts, S., and Stauffer, E. Histological assessment of cartilage repair: a report by the Histology Endpoint Committee of the International Cartilage Repair Society (ICRS). J Bone Joint Surg Am 85-A Suppl 2, 45, 2003.
27. O'Driscoll, S.W., Marx, R.G., Fitzsimmons, J.S., and Beaton, D.E. Method for automated cartilage histomorphometry. Tissue Eng 5, 13, 1999.
28. Sanz, L., Pascual, M., Munoz, A., Gonzalez, M.A., Salvador, C.H., and Alvarez-Vallina, L. Development of a computerassisted high-throughput screening platform for anti-angiogenic testing. Microvasc Res 63, 335, 2002.
29. Grimmer, C., Pfander, D., Swoboda, B., Aigner, T., Mueller, L., Hennig, F.F., and Gelse, K. Hypoxia-inducible factor 1alpha is involved in the prostaglandin metabolism of osteoarthritic cartilage through up-regulation of microsomal prostaglandin E synthase 1 in articular chondrocytes. Arthritis Rheum 56, 4084, 2007.
30. Goldring, M.B., Tsuchimochi, K., and Ijiri, K. The control of chondrogenesis. J Cell Biochem 97, 33, 2006.
31. Ijiri, K., Zerbini, L.F., Peng, H., Correa, R.G., Lu, B., Walsh, N., Zhao, Y., Taniguchi, N., Huang, X.L., Otu, H., Wang, H., Wang, J.F., Komiya, S., Ducy, P., Rahman, M.U., Flavell, R.A., Gravallese, E.M., Oettgen, P., Libermann, T.A., and Goldring, M.B. A novel role for GADD45beta as a mediator of MMP-13 gene expression during chondrocyte terminal differentiation. J Biol Chem 280, 38544, 2005.
32. Yamauchi, M., Imajoh-Ohmi, S., and Shibuya, M. Novel antiangiogenic pathway of thrombospondin-1 mediated by suppression of the cell cycle. Cancer Sci 98, 1491, 2007.
33. Evans, C.H., Liu, F.J., Glatt, V., Hoyland, J.A., Kirker-Head, C., Walsh, A., Betz, O., Wells, J.W., Betz, V., Porter, R.M., Saad, F.A., Gerstenfeld, L.C., Einhorn, T.A., Harris, M.B., and Vrahas, M.S. Use of genetically modified muscle and fat grafts to repair defects in bone and cartilage. Eur Cell Mater 18, 96, 2009.
34. Friedlaender, G.E., Perry, C.R., Cole, J.D., Cook, S.D., Cierny, G., Muschler, G.F., Zych, G.A., Calhoun, J.H., LaForte, A.J., and Yin, S. Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J Bone Joint Surg Am 83-A Suppl 1, S151, 2001.
35. Kurth, T., Hedbom, E., Shintani, N., Sugimoto, M., Chen, F.H., Haspl, M., Martinovic, S., and Hunziker, E.B. Chondrogenic potential of human synovial mesenchymal stem cells in alginate. Osteoarthritis Cartilage 15, 1178, 2007.
36. Tou, L., Quibria, N., and Alexander, J.M. Transcriptional regulation of the human Runx2/Cbfa1 gene promoter by bone morphogenetic protein-7. Mol Cell Endocrinol 205, 121, 2003.
37. Babarina, A.V., Mollers, U., Bittner, K., Vischer, P., and Bruckner, P. Role of the subchondral vascular system in endochondral ossification: endothelial cell-derived proteinases derepress late cartilage differentiation in vitro. Matrix Biol 20, 205, 2001.
38. Taylor, D.K., Meganck, J.A., Terkhorn, S., Rajani, R., Naik, A., O'Keefe, R.J., Goldstein, S.A., and Hankenson, K.D. Thrombospondin-2 influences the proportion of cartilage and bone during fracture healing. J Bone Miner Res 24, 1043, 2009.
39. Posey, K.L., Hankenson, K., Veerisetty, A.C., Bornstein, P., Lawler, J., and Hecht, J.T. Skeletal abnormalities in mice lacking extracellular matrix proteins, thrombospondin-1, thrombospondin-3, thrombospondin-5, and type IX collagen. Am J Pathol 172, 1664, 2008.
40. Bornstein, P. Thrombospondins function as regulators of angiogenesis. J Cell Commun Signal 3, 189, 2009.
41. Jimenez, B., Volpert, O.V., Crawford, S.E., Febbraio, M., Silverstein, R.L., and Bouck, N. Signals leading to apoptosisdependent inhibition of neovascularization by thrombospondin. Nat Med 6, 41, 2000.
42. Oganesian, A., Armstrong, L.C., Migliorini, M.M., Strickland, D.K., and Bornstein, P. Thrombospondins use the VLDL receptor and a nonapoptotic pathway to inhibit cell division in microvascular endothelial cells. Mol Biol Cell 19, 563, 2008.
43. Jou, I.M., Shiau, A.L., Chen, S.Y., Wang, C.R., Shieh, D.B., Tsai, C.S., and Wu, C.L. Thrombospondin 1 as an effective gene therapeutic strategy in collagen-induced arthritis. Arthritis Rheum 52, 339, 2005.
44. Gelse, K., Muhle, C., Knaup, K., Swoboda, B., Wiesener, M., Hennig, F., Olk, A., and Schneider, H. Chondrogenic differentiation of growth factor-stimulated precursor cells in cartilage repair tissue is associated with increased HIF-1alpha activity. Osteoarthritis Cartilage 16, 1457, 2008.
45. Pfander, D., Cramer, T., Deuerling, D., Weseloh, G., and Swoboda, B. Expression of thrombospondin-1 and its receptor CD36 in human osteoarthritic cartilage. Ann Rheum Dis 59, 448, 2000.
46. Armstrong, L.C., Bjorkblom, B., Hankenson, K.D., Siadak, A.W., Stiles, C.E., and Bornstein, P. Thrombospondin 2 inhibits microvascular endothelial cell proliferation by a caspase-independent mechanism.Mol Biol Cell 13, 1893, 2002.
47. Stewart, M.C., Farnum, C.E., and MacLeod, J.N. Expression of p21CIP1/WAF1 in chondrocytes. Calcif Tissue Int 61, 199, 1997.
48. Negishi, Y., Ui, N., Nakajima, M., Kawashima, K., Maruyama, K., Takizawa, T., and Endo, H. p21Cip-1/SDI-1/WAF-1 gene is involved in chondrogenic differentiation of ATDC5 cells in vitro. J Biol Chem 276, 33249, 2001.
49. Canfield, A.E., Sutton, A.B., Hoyland, J.A., and Schor, A.M. Association of thrombospondin-1 with osteogenic differentiation of retinal pericytes in vitro. J Cell Sci 109 (Pt 2), 343, 1996.
50. Rodriguez-Manzaneque, J.C., Lane, T.F., Ortega, M.A., Hynes, R.O., Lawler, J., and Iruela-Arispe, M.L. Thrombospondin-1 suppresses spontaneous tumor growth and inhibits activation of matrix metalloproteinase-9 and mobilization of vascular endothelial growth factor. Proc Natl Acad Sci USA 98, 12485, 2001.
51. Kawata, K., Kubota, S., Eguchi, T., Moritani, N.H., Shimo, T., Kondo, S., Nishida, T., Minagi, S., and Takigawa, M. Role of the low-density lipoprotein receptor-related protein-1 in regulation of chondrocyte differentiation. J Cell Physiol 222, 138, 2010.
52. Adams, J.C., and Lawler, J. The thrombospondins. Int J Biochem Cell Biol 36, 961, 2004.
53. Welsch, G.H., Trattnig, S., Domayer, S., Marlovits, S., White, L.M., and Mamisch, T.C. Multimodal approach in the use of clinical scoring, morphological MRI and biochemical T2-mapping and diffusion-weighted imaging in their ability to assess differences between cartilage repair tissue after microfracture therapy and matrix-associated autologous chondrocyte transplantation: a pilot study. Osteoarthritis Cartilage 17, 1219, 2009.